Scarica l'app Stockscreener
2.06
0.96%
-0.02
Precedente Chiudi:
$2.08
Aprire:
$2.07
Volume 24 ore:
451.21K
Relative Volume:
2.23
Capitalizzazione di mercato:
$35.69M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+13.19%
1M Prestazione:
-14.98%
6M Prestazione:
-44.47%
1 anno Prestazione:
-40.46%
Intervallo 1D:
$2.05
$2.08
Intervallo di 1 settimana:
$1.76
$2.09
Portata 52W:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
Nome
Mural Oncology Plc
Settore
Industria
Telefono
353 1 905 8020
Indirizzo
10 EARLSFORT TERRACE, DUBLIN 2
Confronta MURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.06 | 31.53M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.94 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.38 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.64 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
677.32 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.63 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-04-04 | Iniziato | Morgan Stanley | Overweight |
Mural Oncology Plc Borsa (MURA) Ultime notizie
Xoma, a drug royalty specialist, buys another ‘zombie’ biotech - BioPharma Dive
MURA’s Unexpected Surge: Analyzing Stock Movement - StocksToTrade
Mural Oncology to be Acquired by XRA 5 - citybiz
XOMA Royalty Corporation entered into a definitive agreement to acquire Mural Oncology plc for $35.3 million. - MarketScreener
Mural Oncology To Be Acquired By XOMA Royalty - MSN
Mural Oncology plc enters acquisition agreement with XRA 5 Corp (XOMA Royalty Corporation) - Arthur Cox LLP
After culling 90% of staff, Waltham biotech finds buyer - NBC Boston
MURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Mural Oncology plc Is Fair to Shareholders - MarketScreener
Form 8.3Mural Oncology plc - Business Wire
Citadel Group discloses 1.44% stake in Mural Oncology - Investing.com
Mural Jumps on Partnership with XOMA - Baystreet.ca
XOMA Royalty To Acquire Mural Oncology - Nasdaq
Mural Oncology to be acquired by XRA 5 Corp. for $2.035-$2.24 per share in cash - TipRanks
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share - The Manila Times
XOMA Royalty Unit to Acquire Mural Oncology - MarketScreener
XOMA Royalty to acquire Mural Oncology for up to $2.24 per share - Investing.com
Mural Oncology Announces Entry into Agreement to be - GlobeNewswire
WALTHAM, DUBLIN, EMERYVILLEMural Oncology agrees to acquisition by XOMA Royalty subsidiary - Investing.com
98% Premium: XOMA Royalty Acquires Cancer Drug Developer Mural Oncology in $36.2M Strategic Deal - Stock Titan
Mural Oncology plc Enters Reversal Setup in Weekly ChartsQuarterly Performance Summary & Community Supported Trade Ideas - newsyoung.net
Risk adjusted return profile for Mural Oncology plc analyzedWeekly Risk Summary & Weekly Watchlist for Hot Stocks - Newser
Candlestick signals on Mural Oncology plc stock today2025 Macro Impact & Daily Entry Point Trade Alerts - Newser
Tick level data insight on Mural Oncology plc volatilityShort Setup & Smart Swing Trading Alerts - Newser
Understanding Mural Oncology plc’s price movementJuly 2025 Action & Fast Entry and Exit Trade Plans - Newser
Using flow based indicators on Mural Oncology plcInsider Buying & Safe Capital Investment Plans - Newser
Citadel Group discloses 1.53% stake in Mural Oncology - Investing.com India
Mass. biotech company cuts 90% of workforce - MSN
Citadel Group discloses 1.53% stake in Mural Oncology By Investing.com - Investing.com South Africa
Visual analytics tools that track Mural Oncology plc performanceTreasury Yields & Fast Exit and Entry Trade Guides - Newser
Multi factor analysis applied to Mural Oncology plcWeekly Profit Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Smart tools for monitoring Mural Oncology plc’s price action2025 Trading Volume Trends & Real-Time Volume Spike Alerts - Newser
Is Mural Oncology plc meeting your algorithmic filter criteriaPortfolio Growth Summary & Technical Buy Zone Confirmation - Newser
What technical models suggest about Mural Oncology plc’s comebackInflation Watch & Community Shared Stock Ideas - Newser
Will breakout in Mural Oncology plc lead to full recoveryM&A Rumor & Technical Entry and Exit Alerts - Newser
Will Mural Oncology plc be affected by tariffsQuarterly Performance Summary & Free Safe Capital Growth Stock Tips - sisa-n.com
Can you recover from losses in Mural Oncology plcJuly 2025 Opening Moves & Intraday High Probability Alerts - Newser
Sentiment analysis tools applied to Mural Oncology plcJuly 2025 Outlook & Intraday High Probability Setup Alerts - Newser
Chart based analysis of Mural Oncology plc trendsTrade Risk Summary & Weekly High Return Stock Opportunities - Newser
Citadel Group discloses 1.58% stake in Mural Oncology By Investing.com - Investing.com Canada
Citadel Group discloses 1.58% stake in Mural Oncology - Investing.com
Will Mural Oncology plc Stock Benefit from AI and Green Energy Trends2025 Technical Patterns & Free Community Consensus Stock Picks - Newser
AI Tools Suggest Mural Oncology plc May Outperform This WeekVolume Spike & AI Powered Trade Plan Recommendations - beatles.ru
Mural Oncology shares rise 5.59% premarket after Vanguard Group, Inc. disclosed a position in the company. - AInvest
Sector ETF Data Correlates with Strength in Mural Oncology plcJuly 2025 Highlights & Proven Capital Preservation Methods - beatles.ru
Is Mural Oncology plc a strong candidate for buy and hold2025 Volatility Report & Verified Momentum Stock Ideas - classian.co.kr
Mural Oncology shares rise 1.81% premarket after Vanguard Group, Inc. disclosed a position in the company. - AInvest
Citadel Group discloses 1.17% stake in Mural Oncology By Investing.com - Investing.com India
Is Mural Oncology plc Stock Overbought or Oversold RSI Indicator AnalysisHigh Probability Trade Plan with Indicators - Newser
Mural Oncology Plc Azioni (MURA) Dati Finanziari
Non sono disponibili dati finanziari per Mural Oncology Plc (MURA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Mural Oncology Plc Azioni (MURA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Keson-Brookes Maiken | See Remarks |
Jul 18 '25 |
Sale |
2.48 |
2,158 |
5,352 |
71,406 |
1.38%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):